NewEdge Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7K | Hold |
|
|||||
|
2025
Q1 | $10.8K | Hold |
|
|||||
|
2024
Q4 | $12.6K | Hold |
|
|||||
|
2024
Q3 | $12.9K | Hold |
|
|||||
|
2024
Q2 | $10.1K | Hold |
|
|||||
|
2024
Q1 | $13.5K | Hold |
|
|||||
|
2023
Q4 | $6.6K | Hold |
|
|||||
|
2023
Q3 | $4.65K | Sell |
|
|||||
|
2023
Q2 | $64.4K | Buy |
|
|||||
|
2023
Q1 | $7.8K | Sell |
|
|||||
|
2022
Q4 | $29 | Hold |
|
|||||
|
2022
Q3 | $43K | Sell |
|
|||||
|
2022
Q2 | $46K | Hold |
|
|||||
|
2022
Q1 | $57K | Sell |
|
|||||
|
2021
Q4 | $94K | Hold |
|
|||||
|
2021
Q3 | $135K | Sell |
|
|||||
|
2021
Q2 | $195K | Hold |
|
|||||
|
2021
Q1 | $226K | Sell |
|
|||||
|
2020
Q4 | $396K | Sell |
|
|||||
|
2020
Q3 | $167K | Sell |
|
|||||
|
2020
Q2 | $200K | Sell |
|
|||||
|
2020
Q1 | $121K | Sell |
|
|||||
|
2019
Q4 | $102K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $124K | Sell |
|
|||||
|
2019
Q1 | $144K | Hold |
|
|||||
|
2018
Q4 | $144 | Sell |
|
|||||
|
2018
Q3 | $284K | Hold |
|
|||||
|
2018
Q2 | $271 | Hold |
|
|||||
|
2018
Q1 | $266K | Hold |
|
|||||
|
2017
Q4 | $200K | Sell |
|
|||||
|
2017
Q3 | $268K | Sell |
|
|||||
|
2017
Q2 | $307K | Hold |
|
|||||
|
2017
Q1 | $381K | Buy |
|